Loading
Distinct shells carrying a filed role for this person — not every shell they have ever touched.
Of those vehicles, the ones that closed a merger.
Announced but not closed, and still hunting.
No closed vehicle here has both a stored price and a filed trust value to score it against.
1 vehicle on file, newest listing first
Samuel Merksamer (2) 41 Director Krishna Yeshwant, M.D. (3)(5) 43 Director ____________ (1) As of December 17, 2021 (2) Audit Committee member (3) Compensation and Talent Development Committee member (4) Nominating and Corporate Governance Committee member (5) Research and Development Committee member Executive Officers Melanie Nallicheri Melanie Nallicheri is a co -founder of Legacy EQRx and has been the Chief Executive Officer and a member of the board of directors since September 2021. Ms. Nallicheri was the President and Chief Operating Officer of Legacy EQRx from August 2019 until September 2021. Ms. Nallicheri is a healthcare and life sciences executive with nearly three decades of experience. Prior to joining Legacy EQRx, from September 2016 to April 2019, Ms. Nallicheri served as Chief Business Officer and Head of Biopharma for Foundation Medicine. Prior to that, from 2013 to June 2016, Ms.
This record is keyed to SEC CIK 0001501581 — the identifier this person files under in their own name. Every vehicle above is a filing made under that CIK, so “the same person on two shells” is a fact about an SEC identifier rather than about a name that happens to match.
Roles are the strings the filings used, in the order they were filed. Nothing on this page ranks them, infers seniority, or offers a reason why any two of these names recur — a recurrence is a count, and the filings that produced it are linked beside every row. We also hold 80 institutional-holder rows on these vehicles, under 49 distinct name strings, and none of them is counted across vehicles: that table has no CIK column, and matching holders by name would merge firms that are not the same firm.